Indo-Bangla Pharmaceuticals (DHA:IBP) EV-to-OCF: (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT18.80
View Full Analysis

What is Indo-Bangla Pharmaceuticals EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Indo-Bangla Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its Cash Flow from Operations for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Indo-Bangla Pharmaceuticals's EV-to-OCF at this moment.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's EV-to-OCF or its related term are showing as below:

DHA:IBP's EV-to-OCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11.1
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-10), Indo-Bangla Pharmaceuticals's stock price is BDT18.80. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Indo-Bangla Pharmaceuticals's PE Ratio (TTM) at this moment.

Indo-Bangla Pharmaceuticals  (DHA:IBP) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Indo-Bangla Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.80/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Indo-Bangla Pharmaceuticals EV-to-OCF Related Terms

Indo-Bangla Pharmaceuticals EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals EV-to-OCF Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
EV-to-OCF

Indo-Bangla Pharmaceuticals Semi-Annual Data
EV-to-OCF
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals EV-to-OCF Calculation

Indo-Bangla Pharmaceuticals's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.000/
=

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT18.80
Price